Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt cap
Decision snapshot: DDS stock price vs MMS: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at MMS's multiple
Needs MMS P/E.
Implied fair value · at DDS's multiple
Needs DDS P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: DDS FY 2026 (ended Jan 31, 2026) · MMS FY 2025 (ended Sep 30, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 104% equity / -4% debt · EV / Revenue 1.37x · EV / EBITDA 12.93x
Capital structure 69% equity / 31% debt · EV / Revenue 0.76x · EV / EBITDA 6.25x
DDS carries the larger enterprise value at $8.99B against $4.13B; MMS trades on the lower EV / Revenue multiple (0.76x vs 1.37x); MMS on the lower EV / EBITDA (6.25x vs 12.93x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
DILLARD’S, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Maximus, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
-0.23x
0.80x
Net debt / EBITDA
Leverage against operating earnings
-1.82x
1.68x
Cash and equivalents
Liquid reserves on the balance sheet
$861.46M
$222.35M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Macy's, Inc.
DDS vs M
KOHLS Corp
DDS vs KSS
TJX COMPANIES INC /DE/
DDS vs TJX
NORDSTROM INC
DDS vs JWN
Accenture plc
DDS vs ACN
INTERNATIONAL BUSINESS MACHINES CORP
DDS vs IBM
CACI INTERNATIONAL INC /DE/
DDS vs CACI
ROLLINS INC
DDS vs ROL
CINTAS CORP
DDS vs CTAS
IRON MOUNTAIN INC
DDS vs IRM
-$402.20M
$1.33B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
